quinazolines has been researched along with cromolyn sodium in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Befus, AD; Bienenstock, J; Lee, TD; Shanahan, F | 1 |
| Dunton, AW; McGhee, B; Welton, AF | 1 |
| Aleixandre, MA; Ayala, LE; García Mora, L | 1 |
| Ollrogge, M; Rinast, E; Wiessmann, KJ | 1 |
| Free, CA; Hall, LE | 1 |
| Baruth, H; Crowley, HJ; Hope, WC; Miller, DA; O'Donnell, M; Welton, AF; Yaremko, B | 1 |
| Capiris, T; Herzig, DJ; Kesten, SJ; Sircar, JC | 1 |
| Decker, VL; Schwender, CF; Sunday, BR | 1 |
| Algermissen, B; Bavandi, A; Fischer, E; Handjiski, B; Maurer, M; Paus, R; von Stebut, E | 1 |
2 trial(s) available for quinazolines and cromolyn sodium
| Article | Year |
|---|---|
The pharmacological profile and initial clinical evaluation of tiacrilast (Ro 22-3747): a new antiallergic agent.
Topics: Animals; Asthma; Bronchi; Clinical Trials as Topic; Cromolyn Sodium; Histamine H1 Antagonists; Histamine Release; Humans; Mast Cells; Passive Cutaneous Anaphylaxis; Quinazolines; Rats | 1986 |
[Comparison of the anti-allergic and anti-asthmatic effects of SM 857 (Doqualast) and DNCG].
Topics: Adult; Asthma; Clinical Trials as Topic; Cromolyn Sodium; Double-Blind Method; Female; Humans; Male; Quinazolines; Respiratory Hypersensitivity | 1987 |
7 other study(ies) available for quinazolines and cromolyn sodium
| Article | Year |
|---|---|
Mast cell heterogeneity: effect of anti-allergic compounds on neuropeptide-induced histamine release.
Topics: Animals; Cromolyn Sodium; Dose-Response Relationship, Drug; Histamine Release; Hypersensitivity; Intestinal Mucosa; Male; Mast Cells; Nerve Tissue Proteins; Peritoneal Cavity; Quinazolines; Rats; Rats, Inbred Strains; Theophylline; Thioxanthenes; Xanthones | 1986 |
Evaluation of different drugs in two models of immediate hypersensitivity.
Topics: Animals; Cromolyn Sodium; Diethylcarbamazine; Diltiazem; Female; Guinea Pigs; Histamine H1 Antagonists; Hypersensitivity, Immediate; In Vitro Techniques; Isometric Contraction; Male; Nicardipine; Ovalbumin; Passive Cutaneous Anaphylaxis; Quinazolines; Trachea; Verapamil | 1988 |
Antiallergic properties of SQ 13,847, an orally effective agent. II. Activity in vitro.
Topics: Animals; Cromolyn Sodium; Histamine Release; Hypersensitivity; In Vitro Techniques; Mast Cells; Quinazolines; Rats; Tetrazoles; Thioxanthenes; Xanthones | 1980 |
Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Topics: Aerosols; Anaphylaxis; Animals; Cromolyn Sodium; Drug Evaluation, Preclinical; Guinea Pigs; Histamine Release; Hypersensitivity, Immediate; Ileum; In Vitro Techniques; Lung; Male; Passive Cutaneous Anaphylaxis; Quinazolines; Rats; Rats, Inbred Strains; SRS-A; Thromboxane B2 | 1984 |
Pyrazolo[5,1-b]quinazolin-9-ones: a new series of antiallergic agents.
Topics: Animals; Asthma; Cromolyn Sodium; Passive Cutaneous Anaphylaxis; Pyrazoles; Quinazolines; Rats; Structure-Activity Relationship | 1981 |
Alkaline phosphatase inhibition by a series of pyrido[2,1-b]quinazolines: A possible relationship with cromolyn-like antiallergy activity.
Topics: Alkaline Phosphatase; Animals; Chemical Phenomena; Chemistry; Cromolyn Sodium; Female; Humans; Hypersensitivity; In Vitro Techniques; Leukocytes; Passive Cutaneous Anaphylaxis; Placenta; Pregnancy; Quinazolines; Rats | 1982 |
Activated skin mast cells are involved in murine hair follicle regression (catagen).
Topics: Adrenocorticotropic Hormone; Animals; Cromolyn Sodium; Dose-Response Relationship, Drug; Female; Hair Follicle; Immunohistochemistry; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron; Quinazolines; Skin Physiological Phenomena; Substance P | 1997 |